Tumor bearer T cells suppress BCG-potentiated antitumor responses
- 1 January 1982
- journal article
- research article
- Published by Elsevier in Cellular Immunology
- Vol. 66 (1) , 139-151
- https://doi.org/10.1016/0008-8749(82)90164-2
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Antigen- and receptor-driven regulatory mechanisms. IV. Idiotype-bearing I-J+ suppressor T cell factors induce second-order suppressor T cells which express anti-idiotypic receptors.The Journal of Experimental Medicine, 1980
- Induction of delayed-type hypersensitivity and antitumor immunity by systemic BCGCellular Immunology, 1980
- T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor.The Journal of Experimental Medicine, 1980
- The Effect of Cyclophospkamide on the Immune ResponseJournal of Immunopharmacology, 1979
- The Suppressor-Cell Network in CancerNew England Journal of Medicine, 1978
- Cellular interaction between cytotoxic and suppressor T cells against syngeneic tumors in the mouseCellular Immunology, 1978
- Immunoregulatory circuits among T-cell sets. II. Physiologic role of feedback inhibition in vivo: absence in NZB mice.The Journal of Experimental Medicine, 1978
- Immunoregulatory circuits among T-cell sets. I. T-helper cells induce other T-cell sets to exert feedback inhibition.The Journal of Experimental Medicine, 1978
- Immunosuppressive factor(s) specific for L-glutamic acid(50)-L- tyrosine(50) (GT). II. Presence of I-J determinants on the GT-suppressive factorThe Journal of Experimental Medicine, 1977
- Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses.The Journal of Experimental Medicine, 1975